Our Approach
We are committed to enhancing scientific and technological innovation within the healthcare sector, with a strong focus on Research and Development (R&D) as a strategic cornerstone for achieving sustained progress, growth, and excellence. Our management model, firmly rooted in the principles of continuous improvement, aims to maximize the efficiency and quality of our processes and products.
We actively promote a culture of innovation and collaborative environments that stimulate creativity and the exchange of knowledge among both public and private organizations. Moreover, we place special emphasis on industrial property and technological vigilance as integral components of our innovation approach.
Innovation in numbers
0
R&D Personnel (2022)
0
Number of PhDs
0M€
R&D investment (2022)
0
Ongoing R&D projects
0
Products launched to the market (2022)
0
Patents
Expertise
Oligonucleotides
Delivery
Monoclonal antibodies
Immunodiagnostics
Therapeutics
Enzymes and recombinant proteins
API
Molecular diagnostics
RAW MATERIALS
Design, development, and manufacturing of high-quality biomaterials for diagnosis and mRNA synthesis
DIAGNOSTICS
Precise, fast, and accessible in vitro diagnostic solutions to improve medical care
PHARMA
Technological platform for the design, synthesis, and delivery of mRNA and oligotherapeutics
Oligonucleotides
Monoclonal antibodies
Enzymes and recombinant proteins
RAW MATERIALS
Design, development, and manufacturing of high-quality biomaterials for diagnosis and mRNA synthesis
Immunodiagnostics
Molecular diagnostics
DIAGNOSTICS
Precise, fast, and accessible in vitro diagnostic solutions to improve medical care
Delivery
Therapeutics
API
PHARMA
Technological platform for the design, synthesis, and delivery of mRNA and oligotherapeutics
Resources and capabilities
Interdisciplinary teams
Our R&D and innovation teams are composed of highly qualified specialists with academic backgrounds in a wide range of scientific fields, including chemistry, biotechnology, biochemistry, nanotechnology, and bioinformatics. Over 40% of our R&D staff hold PhDs or bachelor's degrees.
Facilities, laboratories and equipment
Certest has over 26,000 m2 allocated to facilities and laboratories, being one of the largest areas in Europe dedicated to biotechnology. Our facilities house state-of-the art laboratories and cutting-edge equipment, empowering us to spearhead pioneering solutions for both the IVD and biopharmaceutical sectors.
Full product lifecycle
We cover the full product lifecycle, from design to commercialization. Our success is deeply rooted in our knowledge, expertise, and the ability to self-source critical raw materials, ensuring us a consistent supply and independence from third parties.
Industry 4.0
We are in a state of continuous evolution, proactively enhancing our competitiveness by embracing new technologies such as automation, digitalization, AI, bioinformatics, and data analytics. This technological transformation empowers us to streamline our processes, enabling us to respond to market demands swiftly and efficiently with a personalized touch.
Alliances and collaborations
We forge strategic partnerships with both public and private organizations to tackle new challenges and foster the generation of innovative ideas, driving the development of groundbreaking solutions.
